Status:
ENROLLING_BY_INVITATION
Suprazygomatic Maxillary Nerve Block in Cleft Palate Outcomes
Lead Sponsor:
Ann & Robert H Lurie Children's Hospital of Chicago
Conditions:
Cleft Palate Children
Eligibility:
All Genders
9-2 years
Phase:
NA
Brief Summary
Increased pain after cleft palate surgery is the leading cause of increased hospital length of stay, delayed oral intake, readmission, and respiratory compromise. The goal is to improve all outcomes b...
Detailed Description
Cleft palate repair is associated with significant perioperative pain that may require increased depth of anesthesia intraoperatively and can interfere with oral intake and accentuate breathing diffic...
Eligibility Criteria
Inclusion
- All patients undergoing primary cleft palate repair at Ann \& Robert H. Lurie Children's Hospital of Chicago during the enrollment period. The typical child at the time of cleft palate repair is age 11 to 12 months.
Exclusion
- Children with a known allergy to local anesthesia (i.e., ropivacaine or bupivacaine).
- Children with prior surgical repair of the palate.
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04909619
Start Date
March 1 2021
End Date
June 30 2025
Last Update
May 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, United States, 60611